Amneal reports certain preliminary first quarter 2023 financial results and affirms full year 2023 financial guidance

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) announced certain unaudited preliminary financial results for the first quarter ended march 31, 2023. the company is also affirming financial guidance for the year ending december 31, 2023, which was previously issued on march 2, 2023. the company plans to report actual first quarter 2023 financial results on may 5, 2023.
AMRX Ratings Summary
AMRX Quant Ranking